Rolf Muschter

Disclosure information not submitted.

Presentation(s):

• MP73-09: A retrospective clinical service evaluation of lesion-targeted MRI-guided transurethral ultrasound ablation (TULSA) for the treatment of localized prostate cancer

  Monday, May 1, 2023
  7:00 AM – 9:00 AM CST